alpha-ArbutinCAS# 84380-01-8 |
- Arbutin
Catalog No.:BCN6307
CAS No.:497-76-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 84380-01-8 | SDF | Download SDF |
PubChem ID | 158637 | Appearance | White needle crystal |
Formula | C12H16O7 | M.Wt | 272.25 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | H2O : 125 mg/mL (459.14 mM; Need ultrasonic) | ||
Chemical Name | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol | ||
SMILES | C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O | ||
Standard InChIKey | BJRNKVDFDLYUGJ-ZIQFBCGOSA-N | ||
Standard InChI | InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
alpha-Arbutin Dilution Calculator
alpha-Arbutin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.6731 mL | 18.3655 mL | 36.7309 mL | 73.4619 mL | 91.8274 mL |
5 mM | 0.7346 mL | 3.6731 mL | 7.3462 mL | 14.6924 mL | 18.3655 mL |
10 mM | 0.3673 mL | 1.8365 mL | 3.6731 mL | 7.3462 mL | 9.1827 mL |
50 mM | 0.0735 mL | 0.3673 mL | 0.7346 mL | 1.4692 mL | 1.8365 mL |
100 mM | 0.0367 mL | 0.1837 mL | 0.3673 mL | 0.7346 mL | 0.9183 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Bretazenil
Catalog No.:BCC7711
CAS No.:84379-13-5
- Neuromedin S (rat)
Catalog No.:BCC6055
CAS No.:843782-19-4
- Adoxosidic acid
Catalog No.:BCN7593
CAS No.:84375-46-2
- Mifepristone
Catalog No.:BCC4486
CAS No.:84371-65-3
- Bedaquiline
Catalog No.:BCC5246
CAS No.:843663-66-1
- Rabdosin B
Catalog No.:BCN3236
CAS No.:84304-92-7
- 4,4'-Cyclohexylidenebisphenol
Catalog No.:BCC8663
CAS No.:843-55-0
- Pterosin D 3-O-glucoside
Catalog No.:BCN4567
CAS No.:84299-80-9
- Aliarin
Catalog No.:BCN3919
CAS No.:84294-77-9
- 5-O-Methylvisammioside
Catalog No.:BCN4954
CAS No.:84272-85-5
- Raclopride
Catalog No.:BCC7184
CAS No.:84225-95-6
- AKT Kinase Inhibitor
Catalog No.:BCC1335
CAS No.:842148-40-7
- 23-Hydroxybetulin
Catalog No.:BCN6463
CAS No.:84414-40-4
- Fmoc-NH2
Catalog No.:BCC2803
CAS No.:84418-43-9
- AT7519
Catalog No.:BCC2541
CAS No.:844442-38-2
- A-769662
Catalog No.:BCC2080
CAS No.:844499-71-4
- β-CCB
Catalog No.:BCC6635
CAS No.:84454-35-3
- threo-Guaiacylglycerol-beta-O-4'-dehydrodisinapyl ether
Catalog No.:BCN6928
CAS No.:844637-85-0
- C-1
Catalog No.:BCC6687
CAS No.:84468-24-6
- BTS 54-505 hydrochloride
Catalog No.:BCC5901
CAS No.:84484-78-6
- Sibutramine hydrochloride
Catalog No.:BCC5252
CAS No.:84485-00-7
- Varlitinib (ARRY334543)
Catalog No.:BCC3725
CAS No.:845272-21-1
- Sevelamer Carbonate
Catalog No.:BCC4717
CAS No.:845273-93-0
- ICI 162,846
Catalog No.:BCC6808
CAS No.:84545-30-2
Assessment of a Novel Anti-Aging Hand Cream.[Pubmed:27050706]
J Drugs Dermatol. 2016 Apr;15(4):496-503.
There are few creams that have been developed for the purpose of treating the aging hand, yet UV damage and secondary signs of aging on the hands make them one of the most obvious indicators of age outside the face. This study documents results of a 120 day trial using a novel cream preparation containing ingredients including Retinol, alpha-Arbutin, Kojic Dipalmitate, Azaeleic Acid, Hexylresorcinol, Licorice Root, and other ingredients. Results were tabulated comparing physician and patient assessment scores using a comprehensive scoring assay, which showed significant improvements across eight parameters tested. This was statistically significant for physician ratings of texture, wrinkles and pigment at 120 days versus baseline (P < 0.001). Further research is needed, but the results appear to indicate the benefits of a targeted hand cream in improving the appearance of the aging hand.